Tetrahydroxybacteriohopane

Tetrahydroxybacteriohopane

SCHEMBL7896032

C[C@H](CC[C@@H](O)[C@@H](O)[C@@H](O)CO)[C@H]1CC[C@]2(C)[C@H]3CC[C@@H]4[C@@]5(C)CCCC(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@H]12

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.61
GPBAR1 Q8TDU6 3/20 0.37
SLC10A1 Q14973 1/20 0.36
UGT2B7 P16662 7/20 0.33
PLA2G2A P14555 1/20 0.33
RPS6KA5 O75582 2/20 0.33
MAPKAPK2 P49137 2/20 0.33
NR1H4 Q96RI1 2/20 0.32
PRKCD Q05655 1/20 0.32
CDC25A P30304 1/20 0.31
CDC25B P30305 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30864531 0.91 PTPN1 (0.60) PTPN1GPBAR1SLC10A1UGT2B7PLA2G2A
SCHEMBL17866708 0.88 PTPN1 (0.62) PTPN1GPBAR1SLC10A1UGT2B7PLA2G2A
SCHEMBL31490969 0.87 PTPN1 (0.44) PTPN1GPBAR1SLC10A1
SCHEMBL17867266 0.87 PTPN1 (0.46) PTPN1GPBAR1SLC10A1NR1H4PRKCD
SCHEMBL17867295 0.85 PTPN1 (0.74) PTPN1GPBAR1SLC10A1PLA2G2ANR1H4
SCHEMBL29511057 0.85 PTPN1 (0.74) PTPN1GPBAR1SLC10A1PLA2G2ANR1H4
SCHEMBL16432731 0.85 PTPN1 (0.61) PTPN1GPBAR1SLC10A1UGT2B7PLA2G2A
SCHEMBL16432031 0.85 PTPN1 (0.63) PTPN1GPBAR1SLC10A1UGT2B7PLA2G2A
SCHEMBL16433034 0.85 PTPN1 (0.42) PTPN1GPBAR1SLC10A1NR1H4PRKCD
SCHEMBL16431151 0.84 PTPN1 (0.41) PTPN1UGT2B7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494093-B1 METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS NOBLEGEN INC (CA) 2022-05-18 EP claimed
US-10676406-B2 Hopanoids producing bacteria and related biofertilizers, compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2020-06-09 US claimed
US-20190119178-A1 HOPANOIDS PRODUCING BACTERIA AND RELATED BIOFERTILIZERS, COMPOSITIONS, METHODS AND SYSTEMS UNIVERSITY OF NAPOLI FEDERICO II (IT) 2019-04-25 US claimed
US-10131585-B2 Hopanoids producing bacteria and related biofertilizers, compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2018-11-20 US claimed
US-20170107160-A1 HOPANOIDS PRODUCING BACTERIA AND RELATED BIOFERTILIZERS, COMPOSITIONS, METHODS AND SYSTEMS UNIVERSITY OF NAPOLI FEDERICO II (IT) 2017-04-20 US claimed
EP-4608876-A2 ENDOCYTIC AGENTS BioVentures, LLC (US) 2025-09-03 EP disclosed
WO-2025149619-A1 NANOPARTICLES COMPRISING AMPHIPHILIC POLYMERS AND LIPIDS FOR THE TARGETED DELIVERY OF ANTIGENS TOPAS THERAPEUTICS GMBH (DE) 2025-07-17 WO disclosed
CN-119638993-A Polyaspartic acid derivative modified based on hydroxybenzoyl hydrazine, preparation method and application thereof 河南大学 2025-03-18 CN disclosed
CN-119311523-A Self-adaptive buried point system, method and server based on deep reinforcement learning 联通在线信息科技有限公司 2025-01-14 CN disclosed
WO-2024092274-A2 ENDOCYTIC AGENTS BIOVENTURES, LLC (US) 2024-05-02 WO disclosed
WO-2024006022-A1 MEASURING BACKHAUL CHANNEL OF RIS/REPEATER QUALCOMM INCORPORATED (US) 2024-01-04 WO disclosed
WO-2023235592-A2 TLR AGONISTS COMPRISING SAPONIN NANOPARTICLE VACCINE ADJUVANTS TO IMPROVE IMMUNOMODULATION THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2023-12-07 WO disclosed
US-20190210898-A1 METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS TRENT UNIVERSITY (CA) 2019-07-11 US disclosed
US-20190119178-A1 HOPANOIDS PRODUCING BACTERIA AND RELATED BIOFERTILIZERS, COMPOSITIONS, METHODS AND SYSTEMS UNIVERSITY OF NAPOLI FEDERICO II (IT) 2019-04-25 US disclosed
US-10131585-B2 Hopanoids producing bacteria and related biofertilizers, compositions, methods and systems CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2018-11-20 US disclosed
US-20170107160-A1 HOPANOIDS PRODUCING BACTERIA AND RELATED BIOFERTILIZERS, COMPOSITIONS, METHODS AND SYSTEMS UNIVERSITY OF NAPOLI FEDERICO II (IT) 2017-04-20 US disclosed
US-6177415-B1 ENZYME INHIBITORS SPECIFIC TO INHIBIT LIPOXIN BIOSYNTHESIS; TREATMENT OF ATHEROSCLEROSIS/ASTHMA, SIDE EFFECT REDUCTION THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2001-01-23 US disclosed
US-4832833-A Formation of membrane-like material LINNOLA LTD. (IE) 1989-05-23 US disclosed
US-4698148-A Removal of chlorine-based contaminants from materials contaminated the same KEANE JAMES 1987-10-06 US disclosed
US-4610729-A Removal of chlorine-based contaminants from materials contaminated with same LINNOLA LTD. (IE) 1986-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10676406-B2 Hopanoids producing bacteria and related biofertilizers, compositions, methods and systems HPD, BLVRB, FDPS PTPN1 1297/4885GPBAR1 3197/4885SLC10A1 4028/4885
US-10131585-B2 Hopanoids producing bacteria and related biofertilizers, compositions, methods and systems HPD, BLVRB, FDPS PTPN1 1297/4885GPBAR1 3197/4885SLC10A1 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.